News
-
-
-
-
PRESS RELEASE
Evotec receives milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership
Evotec receives US$ 5m milestone payment from Bristol Myers Squibb for IND acceptance in protein degradation partnership, advancing drug candidate towards Phase 1 clinical trial -
-
-
-
PRESS RELEASE
In a landmark industry transaction, Evotec signs agreement with Sandoz, resulting in payments potentially over US$ 650 m plus royalties
Evotec SE signs landmark agreement with Sandoz, leading to over US$650m in payments plus royalties. Deal includes acquisition of manufacturing site and technology license fees -
-
